Biography
Park Soon-jae is a prominent South Korean businessman and biochemist, recognized as the co-founder and CEO of Alteogen, a leading biotechnology firm specializing in biosimilars and bio-betters. Born on December 22, 1954, Park has dedicated his career to the biopharmaceutical industry. His career includes research roles at the Massachusetts Institute of Technology (MIT) and leadership positions at LG Chem and Hanwha Petrochemical. Park's vision led to the founding of Alteogen in 2008, with the company's core technology, Hybrozyme, transforming intravenous biopharmaceuticals into more convenient subcutaneous formulations. In 2024, Forbes estimated his net worth at $3.7 billion. He is recognized for his expertise in research and development, including extensive experience in drug development, clinical trials, and technology licensing. Park is known for his entrepreneurial spirit and strategic partnerships, as seen by the licensing deals with global pharmaceutical companies.
